About Us
Representative Cases
Release Date:2024-12-25
Previous : The case of Shanghai Fosun Pharma’s spin-off of Sisram Medical and listing in Hong Kong was honored with the “Deals of the Year 2017” award by China Business Law Journal.
Return to List
Next: The case of issuance of the 2022 Tier 2 Capital Bonds by Bank of Shanghai was nominated for the ALB “China Regional Law Awards 2023”.